
A new study from the University of Toronto has linked GLP-1 receptor agonists—medications like Ozempic and Wegovy—to an increased risk of developing wet age-related macular degeneration (wet AMD) in people with type 2 diabetes. The research, published in JAMA Ophthalmology, adds to growing concern about the effects of GLP-1 drugs on eye health. What […]Continue Reading